BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20510208)

  • 1. Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray.
    Morse DL; Balagurunathan Y; Hostetter G; Trissal M; Tafreshi NK; Burke N; Lloyd M; Enkemann S; Coppola D; Hruby VJ; Gillies RJ; Han H
    Biochem Pharmacol; 2010 Sep; 80(5):748-54. PubMed ID: 20510208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma.
    Binkley CE; Zhang L; Greenson JK; Giordano TJ; Kuick R; Misek D; Hanash S; Logsdon CD; Simeone DM
    Pancreas; 2004 Nov; 29(4):254-63. PubMed ID: 15502640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
    Iacobuzio-Donahue CA; Maitra A; Shen-Ong GL; van Heek T; Ashfaq R; Meyer R; Walter K; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Am J Pathol; 2002 Apr; 160(4):1239-49. PubMed ID: 11943709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer.
    Balagurunathan Y; Morse DL; Hostetter G; Shanmugam V; Stafford P; Shack S; Pearson J; Trissal M; Demeure MJ; Von Hoff DD; Hruby VJ; Gillies RJ; Han H
    Mol Cancer Ther; 2008 Sep; 7(9):3071-80. PubMed ID: 18765825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands.
    Morse DL; Hostetter G; Balagurunathan Y; Gillies RJ; Han H
    Methods Mol Biol; 2010; 624():195-210. PubMed ID: 20217597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.
    Laurell H; Bouisson M; Berthelemy P; Rochaix P; Dejean S; Besse P; Susini C; Pradayrol L; Vaysse N; Buscail L
    World J Gastroenterol; 2006 Jun; 12(21):3344-51. PubMed ID: 16733850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
    Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
    Argani P; Rosty C; Reiter RE; Wilentz RE; Murugesan SR; Leach SD; Ryu B; Skinner HG; Goggins M; Jaffee EM; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Cancer Res; 2001 Jun; 61(11):4320-4. PubMed ID: 11389052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.
    Han H; Bearss DJ; Browne LW; Calaluce R; Nagle RB; Von Hoff DD
    Cancer Res; 2002 May; 62(10):2890-6. PubMed ID: 12019169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
    Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
    Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
    Zhang Y; Li M; Wang H; Fisher WE; Lin PH; Yao Q; Chen C
    World J Surg; 2009 Apr; 33(4):698-709. PubMed ID: 19030927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.
    Durkin AJ; Bloomston M; Yeatman TJ; Gilbert-Barness E; Cojita D; Rosemurgy AS; Zervos EE
    J Am Coll Surg; 2004 Nov; 199(5):724-31. PubMed ID: 15501112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
    Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
    Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.
    Missiaglia E; Blaveri E; Terris B; Wang YH; Costello E; Neoptolemos JP; Crnogorac-Jurcevic T; Lemoine NR
    Int J Cancer; 2004 Oct; 112(1):100-12. PubMed ID: 15305381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
    Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.